the aid library

IACAPAP

B. Oerbeck

H. Kristensen

K. Manassis

K. R. Overgaard

et al.

J. Fuentes

Joseph M. Rey, Francisco B. Assumpção Jr, Carlos A. Bernad, Füsun Çetin Çuhadaroğlu, Bonnie Evans, Daniel Fung, Gordon Harper, Loïc Loidreau, Yoshiro Ono, Dainius Pūras, Helmut Remschmidt, Brian Robertson, Olga A. Rusakoskaya, Kari Schleimer

K. Munir

M. Bakare

Olivia Fiertag, Sharon Taylor, Amina Tareen & Elena Garralda

United Nations Children's Fund (UNICEF) & International STEP by STEP Association

World Health Organization

World Health Organization WHO

Q 12: In children and adolescents with anxiety disorders, what is the effectiveness and safety, considering system issues in low- and middle-income countries, of using pharmacological interventions in non-specialist settings?

Selective mutism

Mutismo selectivo

Pharmacological interventions for anxiety disorders in children and adolescents

Module 12: Children who Develop Differently - children with disabilities or developmental difficulties

I1. Somatoform disorders

C2. Autism spectrum disorder

J10. History of child psychiatry